Eloxx Pharmaceuticals, Inc.·4

Jan 31, 7:42 PM ET

Ward Robert 4

4 · Eloxx Pharmaceuticals, Inc. · Filed Jan 31, 2019

Insider Transaction Report

Form 4
Period: 2019-01-30
Ward Robert
DirectorChief Executive Officer
Transactions
  • Award

    Stock Options

    2019-01-30+226,000226,000 total
    Exercise: $11.53Exp: 2029-01-30Common Stock (226,000 underlying)
Footnotes (2)
  • [F1]The option vests and becomes exercisable over a four-year period, with one-fourth of the shares of common stock underlying the options vesting on January 30, 2020, and the remainder vests in twelve equal quarterly installments thereafter.
  • [F2]The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan.

Documents

1 file
  • 4
    form4-01312019_040118.xmlPrimary